All Stories

  1. The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?

    Article • PLoS ONE, February 2020, PLOS

    Alessandra Amendola

  2. Evaluation of the Aptima®HIV-1 Quant Dx assay for HIV-1 RNA viral load detection and quantitation in plasma of HIV-1-infected individuals: A comparison with Abbott RealTime HIV-1 assay

    Article • Journal of Medical Virology, February 2016, Wiley

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  3. Autophagy plays an important role in the containment of HIV-1 in nonprogressor-infected patients

    Article • Autophagy, April 2014, Taylor & Francis

    Alessandra Amendola

  4. Ability of Two Commercially Available Assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2.0) To Quantify Low HIV-1 RNA Levels (<1,000 Copies/Milliliter): Comparison with Clinical Samples and NIBSC Working Reagent for Nu...

    Article • Journal of Clinical Microbiology, March 2014, ASM Journals

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  5. Chronic HIV-Infected Patients Show an Impaired Dendritic Cells Differentiation of Bone Marrow CD34+ Cells

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2013, Wolters Kluwer Health

    Alessandra Amendola

  6. HIV-1 drug resistance in recently HIV-infected pregnant mother’s naïve to antiretroviral therapy in Dodoma urban, Tanzania

    Article • BMC Infectious Diseases, September 2013, Springer Science + Business Media

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  7. Erratum to “Standardization and performance evaluation of “modified” and “ultrasensitive” versions of the Abbott RealTime HIV-1 assay, adapted to quantify minimal residual viremia” [J. Clin. Virol. 52 (2011) 17–22]

    Article • Journal of Clinical Virology, February 2012, Elsevier

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  8. Standardization and performance evaluation of “modified” and “ultrasensitive” versions of the Abbott RealTime HIV-1 assay, adapted to quantify minimal residual viremia

    Article • Journal of Clinical Virology, September 2011, Elsevier

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  9. Improving clinical laboratory efficiency: a time-motion evaluation of the Abbott m2000 RealTime and Roche COBAS AmpliPrep/COBAS TaqMan PCR systems for the simultaneous quantitation of HIV-1 RNA and HCV RNA

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), May 2011, De Gruyter

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  10. Effect of raltegravir on the total and unintegrated proviral HIV DNA during raltegravir-based HAART

    Article • Antiviral Therapy, January 2011, International Medical Press

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  11. Minimal residual HIV viremia: verification of the Abbott Real-Time HIV-1 assay sensitivity

    Article • Microbiologia Medica, June 2010, PAGEPress Publications

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  12. Accuracy of a Commercial Real‐Time Polymerase Chain Reaction–Based System for Measurement of HIV RNA Levels around the Limit of Quantification of the Assay

    Article • Clinical Infectious Diseases, June 2009, Oxford University Press (OUP)

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  13. Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vγ9Vδ2 T cells

    Article • AIDS, March 2009, Wolters Kluwer Health

    Alessandra Amendola

  14. Critical Involvement of the ATM-Dependent DNA Damage Response in the Apoptotic Demise of HIV-1-Elicited Syncytia

    Article • PLoS ONE, June 2008, PLOS

    Alessandra Amendola

  15. Differential Expression of Werner and Bloom Syndrome Genes in the Peripheral Blood of HIV-1 Infected Patients

    Article • Human Immunology, February 2007, Elsevier

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  16. Characterization of Cell Death Pathways in Human Immunodeficiency Virus-Associated Encephalitis

    Article • American Journal Of Pathology, September 2005, Elsevier

    Alessandra Amendola

  17. Type 2 Transglutaminase and Cell Death

    Article • January 2005, Karger Publishers

    Alessandra Amendola

  18. Dynamics of viral load rebound in plasma and semen after stopping effective antiretroviral therapy

    Article • AIDS, May 2003, Wolters Kluwer Health

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  19. Transglutaminase Type II Plays a Protective Role in Hepatic Injury

    Article • American Journal Of Pathology, April 2003, Elsevier

    Alessandra Amendola

  20. Tissue transglutaminase in HCV infection

    Article • Cell Death and Differentiation, January 2003, Springer Science + Business Media

    Alessandra Amendola

  21. ‘Tissue’ Transglutaminase and Autoimmunity

    Article • December 2002, Wiley

    Alessandra Amendola

  22. Underevaluation of HIV-1 Plasma Viral Load by a Commercially Available Assay in a Cluster of Patients Infected With HIV-1 A/G Circulating Recombinant Form (CRF02)

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2002, Wolters Kluwer Health

    Alessandra Amendola

  23. Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients

    Article • AIDS, September 2002, Wolters Kluwer Health

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  24. “Tissue” transglutaminase in AIDS

    Article • Journal of Immunological Methods, July 2002, Elsevier

    Alessandra Amendola

  25. Monophyletic HIV Type 1 CRF02-AG in a Nosocomial Outbreak in Benghazi, Libya

    Article • AIDS Research and Human Retroviruses, July 2002, Mary Ann Liebert Inc

    Alessandra Amendola, Dr Maria Rosaria Capobianchi

  26. Tissue transglutaminase in hepatitis C pathogenesis

    Article • Journal of Hepatology, April 2002, Elsevier

    Alessandra Amendola

  27. “Tissue” Transglutaminase Expression in HIV‐Infected Cells

    Article • Annals of the New York Academy of Sciences, November 2001, Wiley

    Alessandra Amendola

  28. ROLE OF DONOR AND RECIPIENT ANTIGEN-PRESENTING CELLS IN PRIMING AND MAINTAINING T CELLS WITH INDIRECT ALLOSPECIFICITY1

    Article • Transplantation, November 1998, Wolters Kluwer Health

    Alessandra Amendola

  29. Ceramide-Induced Apoptosis Is Mediated by Caspase Activation Independently from Retinoblastoma Protein Post-Translational Modification

    Article • Biochemical and Biophysical Research Communications, February 1998, Elsevier

    Alessandra Amendola

  30. Lack of ‘tissue’ transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells: relationship to development of autoimmunity in MRLlpr/lpr mice

    Article • Cell Death and Differentiation, August 1997, Springer Science + Business Media

    Alessandra Amendola, Dr Vittorio Gentile

  31. Stem Cell Factor Regulation of Apoptosis in Mouse Primordial Germ Cells

    Article • January 1997, Springer Science + Business Media

    Alessandra Amendola, Dr Maurizio Pesce

  32. HIV‐1 gp120‐dependent induction of apoptosis in antigen‐specific human T cell clones is characterized by ‘tissue’ transglutaminase expression and prevented by cyclosporin A

    Article • FEBS Letters, February 1994, Wiley

    Alessandra Amendola